Clofarabine as a potential stimulant of alloreactivity

被引：2

作者：

Atimere, N. ^{[1
]}

Zriba, S. ^{[1
]}

Hicheri, Y. ^{[1
]}

Pautas, C. ^{[1
]}

Cordonnier, C. ^{[1
]}

Maury, S. ^{[1
]}

机构：

[1] CHU Henri Mondor, Dept Hematol, F-94010 Creteil, France

来源：

BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 10期

关键词：

VERSUS-HOST-DISEASE; DONOR LYMPHOCYTE INFUSIONS; LEUKEMIA;

D O I：

10.1038/bmt.2010.309

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1393 / 1394

页数：2

共 9 条

[1] Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma [J].

Dudley, ME ;

Wunderlich, JR ;

Yang, JC ;

Sherry, RM ;

Topalian, SL ;

Restifo, NP ;

Royal, RE ;

Kammula, U ;

White, DE ;

Mavroukakis, SA ;

Rogers, LJ ;

Gracia, GJ ;

Jones, SA ;

Mangiameli, DP ;

Pelletier, MM ;

Gea-Banacloche, J ;

Robinson, MR ;

Berman, DM ;

Filie, AC ;

Abati, A ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2346-2357

[2] Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen:: lack of association with cell dose [J].

Fozza, C. ;

Szydlo, R. M. ;

Abdel-Rehim, M. M. ;

Nadal, E. ;

Goldman, J. M. ;

Apperley, J. F. ;

Dazzi, F. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (06) :833-836

[3] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia [J].

Jeha, S ;

Gaynon, PS ;

Razzouk, BI ;

Franklin, J ;

Kadota, R ;

Shen, V ;

Litchtman-Jones, L ;

Rytting, M ;

Bomgaars, LR ;

Rheingold, S ;

Ritchey, K ;

Albano, E ;

Arceci, RJ ;

Goldman, S ;

Griffin, T ;

Altman, A ;

Gordon, B ;

Steinherz, L ;

Weitman, S ;

Steinherz, P .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) :1917-1923

[4] Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia [J].

Kantarjian, H ;

Gandhi, V ;

Cortes, J ;

Verstovsek, S ;

Du, M ;

Garcia-Manero, G ;

Giles, F ;

Faderl, S ;

O'Brien, S ;

Jeha, S ;

Davis, J ;

Shaked, Z ;

Craig, A ;

Keating, M ;

Plunkett, W ;

Freireich, EJ .

BLOOD, 2003, 102 (07) :2379-2386

[5] Graft-versus-leukemia effects of transplantation and donor lymphocytes [J].

Kolb, Hans-Jochem .

BLOOD, 2008, 112 (12) :4371-4383

[6]

MACKINNON S, 2008, ASCO 2008 ED BOOK, P334

[7] Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice [J].

Maury, S ;

Salomon, B ;

Klatzmann, D ;

Cohen, JL .

BLOOD, 2001, 98 (10) :3156-3158

[8] Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone [J].

Miller, Jeffrey S. ;

Weisdorf, Daniel J. ;

Burns, Linda J. ;

Slungaard, Arne ;

Wagner, John E. ;

Verneris, Michael R. ;

Cooley, Sarah ;

Wangen, Rosanna ;

Fautsch, Susan K. ;

Nicklow, Roby ;

Defor, Todd ;

Blazar, Bruce R. .

BLOOD, 2007, 110 (07) :2761-2763

[9] Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions [J].

Raiola, AM ;

Van Lint, MT ;

Valbonesi, M ;

Lamparelli, T ;

Gualandi, F ;

Occhini, D ;

Bregante, S ;

di Grazia, C ;

Dominietto, A ;

Soracco, M ;

Romagnani, C ;

Vassallo, F ;

Casini, M ;

Bruno, B ;

Frassoni, F ;

Bacigalupo, A .

BONE MARROW TRANSPLANTATION, 2003, 31 (08) :687-693

← 1 →